Verastem, Inc. (VSTM)
6.33
-0.53
(-7.73%)
USD |
NASDAQ |
Nov 20, 16:00
6.34
+0.01
(+0.16%)
After-Hours: 20:00
Verastem Cash and Short Term Investments (Annual) : 204.99M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 204.99M |
| December 31, 2024 | 88.82M |
| December 31, 2023 | 138.06M |
| December 31, 2022 | 87.89M |
| December 31, 2021 | 100.26M |
| December 31, 2020 | 141.23M |
| December 31, 2019 | 75.51M |
| December 31, 2018 | 250.39M |
| Date | Value |
|---|---|
| December 31, 2017 | 86.83M |
| December 31, 2016 | 80.90M |
| December 31, 2015 | 110.26M |
| December 31, 2014 | 92.68M |
| December 31, 2013 | 101.31M |
| December 31, 2012 | 56.58M |
| December 31, 2011 | 47.81M |
| December 31, 2010 | 100.74M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.193B |
| Cytokinetics, Inc. | 885.34M |
| Inovio Pharmaceuticals, Inc. | 58.51M |
| Rigel Pharmaceuticals, Inc. | 154.96M |
| United Therapeutics Corp. | 2.920B |